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Background/Aim: Current evidence in the literature supports associations between
frailty, cognitive impairment, and dementia. The study aim was to describe the
risk of cognitive disorders associated with physical frailty in older adults from
community-based studies.
Methods: We performed a systematic review and meta-analysis, using MEDLINE,
PsycINFO, Scopus, and Web of Science as databases for the search. Cohort and
longitudinal studies were included in qualitative analysis and quantitative synthesis. For
inclusion, studies had to assess dementia and cognitive impairment as a primary or
secondary outcome, and describe the prevalence of frailty among participants at baseline
and follow-up.
Results: Of the 2,210 studies retrieved by the systematic review, 6 relevant studies were
included in a meta-analysis. Baseline frailty was significantly associated with an increased
risk of geriatric cognitive disorders (pooled OR = 1.80, 95% CI = 1.11–2.92; p = 0.02).
Heterogeneity across the studies was significant (I2 = 79%).
Conclusions: The analyses confirmed that frail older adults were at higher risk of
incident cognitive disorders than non-frail elders. Frailty status seems to be most
associated with the risk of incident dementia. Frailty may represent a risk factor for
dementia and could constitute a novel modifiable target in early cognitive impairment.
Keywords: mild cognitive impairment, cognitive decline, dementia, cognitive disorders, comorbidity, elderly,
meta-analysis
INTRODUCTION
From its definition, frailty can be understood as a state of higher vulnerability to stressors attributed
to a lower homeostatic reserve due to an age-related multisystem physiological change (1). Frailty
refers to a potentially reversible pathological aging process that occurs at an intermediate stage
between aging-related diseases (senility) and relevant adverse outcomes such as disability and death
(2). It is a common geriatric condition with a mean prevalence of 10% (3). Gill et al. conducted a
study investigating risk factors associated with disability in the last year of life and reported that
frailty was the condition most frequently leading to death (4).
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Several types of operational definitions have emerged
contributing to the diagnosis of frailty, ranging from physical
or phenotype criteria [e.g., Fried’s phenotype criteria (1)] to
multidimensional models [e.g., Frailty Index (5)]. A third frailty
model warranting special attention is the biopsychosocial model
(another multidimensional model) which combines physical and
psychosocial domains (6). This construct is oriented toward the
social sciences and emphasizes the importance of an integral
conceptual definition of frailty (7). In general, independently of
the validated criteria used, the diagnosis of frailty is associated
with adverse health outcomes (falls, disability, hospitalization,
institutionalization, or death) (2).
Current evidence in the literature from cross-sectional and
longitudinal studies has shown relationships between frailty
and cognitive disorders (including mild cognitive impairment
and dementia) (8–10). Frailty may increase the future risk
of mild cognitive impairment (MCI) and all-cause dementia
in cognitively unimpaired populations, as well as accelerate
cognitive decline of these individuals (11). Furthermore,
components of frailty appeared to be related to pathological
findings of Alzheimer’s disease (AD) and vascular dementia,
supporting the notion of a possible common biological pathway
between frailty and cognitive disorders (12, 13). Despite this
evidence, there is debate over the magnitude of the association
between frailty and cognitive impairment. Some longitudinal
studies show that frailty is associated with dementia, especially
vascular dementia (14–16). Frailty was identified retrospectively,
or using non-validated criteria, in many other studies (10, 13,
17, 18). Additionally, in previous systematic reviews and meta-
analyses, more recently published studies were not included and
the number of incident cognitive impairment cases among frail
participants was not clearly reported (19–21).
Interest in this field of research has been growing rapidly
in the past 5 years (22, 23). It is thus essential to define
the relevant aspects that are useful for the definition of the
construct of cognitive frailty for use in both clinical practice
and research (22, 23). Therefore, the understanding of the
relationship between frailty and geriatric cognitive disorders
could contribute to new interventions for the prevention and
management of both conditions. Finally, the main objective of
this systematic review and meta-analysis was to describe the risk
of development of cognitive disorders in previously cognitively
unimpaired community-dwelling older adults or those with
MCI associated with frailty at baseline from longitudinal and
cohort studies.
METHODS
Data Source and Search Strategy
A systematic literature search of PubMed (MEDLINE), SCOPUS,
PsycINFO, and Web of Science from 1st March 2001 through
January 2018 was conducted according to the Standards for
Systematic Reviews (24) and the Preferred Reporting Items
for Systematic Review and Meta-Analyses (PRISMA) guidelines
(25). The publication period was decided based on the most
widely used definition of frailty, Fried’s phenotype criteria (1),
published on 1st March, 2001. In addition to the date limit,
the following filters were used: English language, humans,
aged 65 years or older. The inclusion criteria were: (i) older
adults without dementia at baseline; (ii) community-dwelling
population; (iii) cohort or longitudinal studies; (iv) frailty defined
according to common, validated and recognized criteria, and
evaluated prospectively; (v) incidence of geriatric cognitive
disorders at the end of a follow-up of at least 2 years; and
finally; (vi) if dementia was the main outcome, it had to be
diagnosed based on well-known established criteria such as the
Diagnostic and Statistical Manual of Mental Disorders (DSM)
(26) or National Institute of Neurological and Communicative
Disorders and Stroke, Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA) (27) or National Institute of
Neurological Disorders and Stroke, Association Internationale
pour la Recherche et l’Enseignement en Neurosciences (NINDS-
AIREN) (28).
The search terms used included the following:
[(“cognition”[MeSH] OR “cognition”) OR (“cognitive
dysfunction”[MeSH] OR (“cognitive” AND “dysfunction”)
OR “cognitive dysfunction” OR (“mild” AND “cognitive”
AND “impairment” OR “mild cognitive impairment”) OR
(“dementia”[MeSH] OR “dementia”)] AND [(“frailty”[MeSH]
OR “frailty”) OR (“frail elderly”[MeSH] OR (“frail” AND
“elderly”) OR “frail elderly”)]. The bibliographies of relevant
reviews and meta-analyses involving frailty and cognitive
impairment were also manually searched and additional
references obtained from outside experts.
Study Selection
Two independent authors reviewed each study abstract according
to the inclusion criteria, and the full text of all studies retrieved
by the literature search for eligibility. Cohort and longitudinal
studies that assessed dementia and cognitive impairment as a
primary or secondary outcome and described the prevalence
of frailty among participants at baseline were included in
the quantitative synthesis. Only studies conducted among
community-dwelling older adults were included. Studies that
were reviews, editorials or letters, clinical, and cross-sectional
studies were excluded. Any disagreement over studies selected
by any of the authors was resolved by consensus of the
authors involved.
Data Extraction and Quality Assessment
Two authors extracted the data according to a predefined
format for presentation: author, year; population, exposures,
comparators, outcomes, and study design. The authors abstracted
study design information, population characteristics at baseline,
exposure details, disease prevalence at baseline, and incidence at
the end of follow-up, and risk estimates such as OR (Odds ratio)
or HR (Hazard ratio) with 95% confidence intervals (95%CI)
from all included studies into a standardized table. Two authors
assessed the quality and risk of bias for each study included in the
qualitative analysis. The Newcastle-Ottawa Quality Assessment
Scale (29) was used for this evaluation of quality, where each
study was assessed for good standards on four items of selection,
one item of comparability, and three items of outcome, yielding
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a total of 8 stars (points) (comparability can be scored with up to
two stars).
Data Synthesis and Analysis
All evidence drawn from the studies was described qualitatively
and summarized in Table 1. We also analyzed the results from
the studies using quantitative estimates of effects by the Mantel-
Haenszel method. Thus, a random-effects meta-analysis was
conducted to estimate the odds ratio of cognitive decline between
frail and non-frail participants using the RevMan software,
version 5.3 (Review Manager (RevMan) [Computer program].
Version 5.3. Copenhagen: The Nordic Cochrane Center, The
Cochrane Collaboration, 2014). Confidence interval was set at
95%, and the level of significance was set at <5%.
RESULTS
Selection Process
The systematic search of the literature yielded 2,200 citations.
A further 10 studies had not been identified and were added
manually. Of the 2,210 records, 867 studies were removed by
search filters: publication period (March, 2001 to January, 2018),
English language, humans, aged over 65 years. Of the 1,343
records, 1,258 studies considered not relevant were excluded,
giving a total of 85 studies for full-text review. Twenty-one
reviews, nine editorials or letters; eight clinical studies; and eight
cross-sectional studies were subsequently excluded. Five studies
were excluded for not categorizing frailty status or showing an
association with MCI and dementia. Of the remaining thirty-
four studies, twenty-eight were excluded for not fulfilling the
criteria for this study. The complete list of excluded studies
can be found in the Supplementary File. The remaining six
studies were considered to have adequate methodological quality
and included in the qualitative and quantitative syntheses
(meta-analysis). Figure 1 depicts the flowchart of the study
selection process.
Study and Participant Characteristics
Study and participant characteristics of the cohort or population-
based longitudinal studies are summarized in Table 1. The
studies were conducted among community-dwellers in North
America (n = 2); Europe (n = 3); and Asia (n = 1). Sample size
ranged from 1,575 to 5,480 (total of 14,657 participants). Mean
age of study participants was 73.3 years. The overall quality of
the studies assessed using NOS was high, with a median score
of 8 (Table 1).
Longitudinal Meta-Analysis Findings
There were 936 frail older adults in the 6 studies (14–16, 30–
32) investigating the incidence of cognitive disorders over a
mean follow-up of 5.33 years (range 3 to 7 years). These
subjects were compared with 13,721 non-frail individuals at
baseline (Figure 2).
Results showed that baseline frailty was significantly
associated with an increased risk of geriatric cognitive disorders
(pooled OR = 1.80, 95% CI = 1.11–2.92 p = 0.02; I2 = 79%),
as shown in Figure 2. Heterogeneity across the studies was
significant (I2 = 79%).
Frailty and the Risk of Geriatric Cognitive
Disorders
Frail status was most associated with the risk of dementia,
particularly non-AD and vascular dementia, even after adjusting
for many confounders, as shown in Table 1.
In the Three-City study (14), frailty was a major risk factor
for incident dementia and was associated with greater risk of all
types of dementia. In the ILSA study (16), physical frailty was
associated with a significantly increased risk of overall dementia
and vascular dementia over a 3.5-year follow-up, while the risk
of AD or other types of dementia did not significantly change in
frail individuals compared with robust older adults. Later studies
confirm the impact of frailty on incident vascular and overall
dementia, but not AD dementia (15, 31). Frail participants did
not exhibit a significant risk for incident dementia in the Gait
and Brain Study (32).
There were major disparities in definitions of cognitive
impairment and assessments of cognitive functioning. Most
studies employed different methods (e.g., MMSE, MoCA)
and cut-off values for defining cognitive impairment. Several
studies evaluated the cognitive performance of participants using
screeningmeasures of global cognition. Only two studies adopted
a comprehensive neuropsychological test battery (14, 15) and
CDR scale (30, 32). Only one study showed that PF was associated
with both incident cognitive impairment and greater risk of
neurocognitive disorders (NCD) in older adults (30).
DISCUSSION
In this systematic review and meta-analysis, the relationship
between frailty, and cognitive disorders was investigated,
summarizing data from longitudinal and cohort studies involving
community-dwelling older adults. Our analyses confirmed that
frail older adults were at higher risk of incident cognitive
disorders, especially vascular dementia, compared with non-frail
elders. Previous longitudinal studies have reported that physical
frailtymay be associated with incident vascular dementia (14, 16).
In fact, physical frailty was associated with increased risk of
developing vascular dementia in three of the studies included in
the present systematic review (14, 16, 31).
Vascular dementia is caused by cardiovascular disease (CVD).
It has been suggested that CVD and vascular cognitive
impairment (cerebrovascular disease) in the elderly have the
same risk factors (33). Frailty has been associated with an
increased odds for hypertension and diabetes (34, 35). Atrial
fibrillation (AF) is another major risk factor for cerebrovascular
disease. A recent systematic review investigating the association
between AF and frailty shows that a higher prevalence of
frailty was observed among patients with this CVD (36).
Veronese et al. conducted a study showing that frailty is an
independent risk factor for any-type of CVD in older adults
(37). Moreover, studies have shown that obesity and metabolic
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FIGURE 1 | Flowchart of the systematic search.
FIGURE 2 | Random-effects meta-analysis of incident cognitive disorder associated with frailty in older adults.
disorders are associated with cognitive decline and dementia (38–
40). Metabolic Syndrome and insulin resistance are associated
with increased risk of frailty (41). However, current evidence on
Metabolic Syndrome and risk for cognitive decline in the elderly
is conflicting (42).
Physical frailty has been associated with late-life cognitive
decline, incident AD and mild cognitive impairment, vascular
dementia, and with non-AD dementia in older adults according
to findings of previous systematic reviews (19–21). Several
studies examining frailty and cognitive impairment suggest these
outcomes interact and the existence of a possible bidirectional
relationship (23). A pooled prevalence of physical frailty of
32% in patients with AD was reported in a previous systematic
review (43).
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Cognitive impairment has been considered either a syndrome
(e.g., MCI, Subjective Cognitive Decline (SCD), NCD, or
cognitive frailty when combined with frailty diagnosis) or a
preclinical stage of AD (prodromal AD or preclinical AD)
(44). Moreover, studies show a higher prevalence of cognitive
impairment among frail older people (45). In our review, we
found two studies that considered other outcomes related to
cognition (cognitive impairment and cognitive decline) (30, 32).
A 5-year longitudinal study revealed that physical impairment in
individuals considered cognitively normal could lead to cognitive
impairment clinically detectable only later and was associated
with a greater risk of developing dementia of the AD type (46).
However, it is important to emphasize that the causes of physical
frailty and cognitive impairment are not well-established (47).
The etiology of frailty is possibly complex and might
be multidimensional, including variables such as cognition,
mood, nutrition, mobility, physical activity, strength, balance,
endurance, coping, relationship, and social support, among other
potential causes (47). Inflammation and oxidative stress are two
factors that also play an important role in the development of
both frailty and cognitive impairment (48). Frailty components
have been linked to typical pathophysiological changes seen
in AD (e.g., amyloid deposition) (13). However, it remains
unclear whether the association is due to a direct (e.g.,
amyloid deposits are cause of frailty) or indirect (e.g., amyloid
accumulation is related to frailty because they are both age-
related conditions) mechanism.
At the same time, improved discrimination of
neurodegenerative conditions from disturbances caused by
disruption of the homeostatic balance (e.g., frailty; indirectly
responsible for cognitive impairment) will impact clinical and
research strategies (49). In particular, the impact of several
operational definitions of frailty on cognitive decline has been
attracting interest in this field of research. Cognitive frailty
could be a heterogeneous clinical syndrome, characterized by
concomitant physical frailty and MCI, while excluding cases
with AD or other dementias (23). More recently, the construct
of cognitive frailty proved capable of predicting short- and
long-term all-cause mortality and overall dementia, particularly
vascular dementia (31).
Strengths and Limitations
These comprehensive meta-analysis results advance the
literature beyond previously published integrative (50, 51)
and/or systematic reviews (19–21) that have explored the
relationship between cognitive impairment or dementia and
frailty. The present review only included high-quality studies
involving a prospective diagnosis of frailty according to validated
criteria. Additionally, all studies reported the number of frail
participants with incident cognitive disorders, while dementia
diagnosis was based on established criteria.
Our data should be interpreted with caution because
of potential limitations. First, the number of longitudinal
prospective studies was limited. Second, most studies applied
modified frailty criteria compared with the original. Third,
significant heterogeneity was observed across the studies
included in this review.
Lastly, in some studies, it is unclear whether the identification
of participants with dementia resulted from a comprehensive
assessment of cognitive and functional abilities (as required
by current diagnostic criteria) or was merely based on global
screening measures (e.g., the MMSE). Therefore, future research
is required to understand how different operational definitions of
frailty and cognitive impairment are useful and clearly defined as
an integral concept.
Finally, frailty may represent a novel modifiable target in early
cognitive impairment. Identification of modifiable risk factors
for cognitive frailty will improve identification of high-risk
individuals and help develop interventions to prevent cognitive
decline in aging. Physical frailty and cognition together, in the
absence of dementia, may have important implications in clinical
settings and research scenarios worldwide.
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